Adipose-induced EMT in breast cancer cells can be reversed by inhibition of the IL-6/STAT3 signaling axis, by using U.S. food and drug administration (FDA)-approved anthelmintic niclosamide [31]. Here, STAT3 is linked to breast carcinoma.